Search

Author/Creator Fereshteh, Mark

1. 238 Molecular dissection of tumor-immune microenvironment factors associated with response to checkpoint inhibitor therapy in non-small cell lung cancer patients using nanostring digital spatial profiling. (9th November 2020)

Authors:
Jabado, Omar; Couto, Suzana; Blum, Jordan; Franken, Patrick; Souza, Patricia Coutinho de; Jure-Kunkel, Maria; Pencheva, Nora; Higgs, Brandon; Sasser, Kate; Fereshteh, Mark
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A255
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 238 Molecular dissection of tumor-immune microenvironment factors associated with response to checkpoint inhibitor therapy in non-small cell lung cancer patients using nanostring digital spatial profiling. (10th December 2020)

Authors:
Jabado, Omar; Couto, Suzana; Blum, Jordan; Franken, Patrick; Souza, Patricia Coutinho de; Jure-Kunkel, Maria; Pencheva, Nora; Higgs, Brandon; Sasser, Kate; Fereshteh, Mark
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A141
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 561 DuoBody®-PD-L1×4–1BB (GEN1046) induces superior immune-cell activation, cytokine production and cytotoxicity by combining PD-L1 blockade with conditional 4–1BB co-stimulation. (10th December 2020)

Authors:
Muik, Alexander; Altintas, Isil; Kosoff, Rachelle; Gieseke, Friederike; Schödel, Kristina; Salcedo, Theodora; Burm, Saskia; Toker, Aras; Kranz, Lena; Vormehr, Mathias; Eisel, David; Fereshteh, Mark; Türeci, Özlem; Breij, Esther; Ahmadi, Tahamtan; Sahin, Ugur; Jure-Kunkel, Maria
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A338
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 561 DuoBody®-PD-L1×4–1BB (GEN1046) induces superior immune-cell activation, cytokine production and cytotoxicity by combining PD-L1 blockade with conditional 4–1BB co-stimulation. (9th November 2020)

Authors:
Muik, Alexander; Altintas, Isil; Kosoff, Rachelle; Gieseke, Friederike; Schödel, Kristina; Salcedo, Theodora; Burm, Saskia; Toker, Aras; Kranz, Lena; Vormehr, Mathias; Eisel, David; Fereshteh, Mark; Türeci, Özlem; Breij, Esther; Ahmadi, Tahamtan; Sahin, Ugur; Jure-Kunkel, Maria
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A595
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity. Issue 6 (10th June 2022)

Authors:
Muik, Alexander; Adams III, Homer C; Gieseke, Friederike; Altintas, Isil; Schoedel, Kristina B; Blum, Jordan M; Sänger, Bianca; Burm, Saskia M; Stanganello, Eliana; Verzijl, Dennis; Spires, Vanessa M; Vascotto, Fulvia; Toker, Aras; Quinkhardt, Juliane; Fereshteh, Mark; Diken, Mustafa; Satijn, Dav...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 6(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Heterobicyclic inhibitors of transforming growth factor beta receptor I (TGFβRI). Issue 5 (1st March 2018)

Authors:
Harikrishnan, Lalgudi S.; Warrier, Jayakumar; Tebben, Andrew J.; Tonukunuru, Gopikishan; Madduri, Sudhakara R.; Baligar, Vishweshwaraiah; Mannoori, Raju; Seshadri, Balaji; Rahaman, Hasibur; Arunachalam, P.N.; Dikundwar, Amol G.; Fink, Brian E.; Fargnoli, Joseph; Fereshteh, Mark; Fan, Yi; Lippy, J...
Journal:
Bioorganic & medicinal chemistry
Issue:
Volume 26:Issue 5(2018)
Page Start:
1026
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗